Current and historical daily PE Ratio for Remed Co Ltd (
) from 2018 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Remed stock (XKRX:302550) PE ratio as of Jun 09 2024 is 250.7.
More Details
Remed Co Ltd (XKRX:302550) PE Ratio (TTM) Chart
Remed Co Ltd (XKRX:302550) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1215
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Remed PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 250.7 | 2024-04-01 | 198.9 |
| 2024-06-07 | 250.7 | 2024-03-29 | 194.0 |
| 2024-06-05 | 245.8 | 2024-03-28 | 195.4 |
| 2024-06-04 | 238.0 | 2024-03-27 | 148.2 |
| 2024-06-03 | 246.5 | 2024-03-26 | 150.0 |
| 2024-05-31 | 239.1 | 2024-03-25 | 150.8 |
| 2024-05-30 | 248.9 | 2024-03-22 | 150.5 |
| 2024-05-29 | 246.8 | 2024-03-21 | 151.6 |
| 2024-05-28 | 251.8 | 2024-03-20 | 151.6 |
| 2024-05-27 | 252.1 | 2024-03-19 | 152.4 |
| 2024-05-24 | 257.8 | 2024-03-18 | 154.7 |
| 2024-05-23 | 262.3 | 2024-03-15 | 149.5 |
| 2024-05-22 | 258.4 | 2024-03-14 | 148.4 |
| 2024-05-21 | 252.1 | 2024-03-13 | 148.9 |
| 2024-05-20 | 249.7 | 2024-03-12 | 143.9 |
| 2024-05-17 | 256.0 | 2024-03-11 | 145.3 |
| 2024-05-16 | 248.2 | 2024-03-08 | 149.5 |
| 2024-05-14 | 245.1 | 2024-03-07 | 143.9 |
| 2024-05-13 | 246.5 | 2024-03-06 | 141.8 |
| 2024-05-10 | 256.7 | 2024-03-05 | 143.7 |
| 2024-05-09 | 241.2 | 2024-03-04 | 147.9 |
| 2024-05-08 | 207.8 | 2024-02-29 | 150.3 |
| 2024-05-07 | 200.0 | 2024-02-28 | 148.7 |
| 2024-05-03 | 198.9 | 2024-02-27 | 156.1 |
| 2024-05-02 | 203.5 | 2024-02-26 | 147.6 |
| 2024-04-30 | 201.8 | 2024-02-23 | 151.1 |
| 2024-04-29 | 200.3 | 2024-02-22 | 147.9 |
| 2024-04-26 | 196.1 | 2024-02-21 | 146.8 |
| 2024-04-25 | 193.7 | 2024-02-20 | 144.7 |
| 2024-04-24 | 194.4 | 2024-02-19 | 143.9 |
| 2024-04-23 | 194.7 | 2024-02-16 | 149.2 |
| 2024-04-22 | 194.4 | 2024-02-15 | 145.3 |
| 2024-04-19 | 195.8 | 2024-02-14 | 146.1 |
| 2024-04-18 | 198.2 | 2024-02-13 | 150.0 |
| 2024-04-17 | 196.5 | 2024-02-08 | 151.6 |
| 2024-04-16 | 195.1 | 2024-02-07 | 155.0 |
| 2024-04-15 | 195.1 | 2024-02-06 | 151.6 |
| 2024-04-12 | 192.3 | 2024-02-05 | 152.6 |
| 2024-04-11 | 198.6 | 2024-02-02 | 153.9 |
| 2024-04-09 | 201.8 | 2024-02-01 | 148.4 |
| 2024-04-08 | 196.5 | 2024-01-31 | 150.8 |
| 2024-04-05 | 197.2 | 2024-01-30 | 153.7 |
| 2024-04-04 | 190.8 | 2024-01-29 | 153.4 |
| 2024-04-03 | 194.0 | 2024-01-26 | 156.3 |
| 2024-04-02 | 196.5 | 2024-01-25 | 162.1 |
Remed Co Ltd (XKRX:302550) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Remed Co Ltd
ISIN : KR7302550009
Share Class Description:
XKRX:302550: Ordinary SharesCompare
Compare
Traded in other countries / regions
302550.Korea IPO Date
2018-08-14Description
Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers